SEC Form 4 · accession 0001225208-15-011802

Merck & Co., Inc. · MRK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP Strat Comm, Gl Pub Policy

Period of report

May 8, 2015

Accepted (ET)

May 11, 2015 · 1:33 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000310158

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	May 8, 2015	M	27,000	$36.56	A	51,145	D
Common Stock	May 8, 2015	M	19,208	$33.49	A	70,353	D
Common Stock^F1,F2	May 8, 2015	S	38,368	$60.987	D	31,985	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F3	$36.56	May 8, 2015	M	27,000	D	May 4, 2012	May 3, 2021	Common Stock	27,000	10,313	D
Stock Option (right to buy)^F4	$33.49	May 8, 2015	M	19,208	D	May 7, 2011	May 6, 2020	Common Stock	19,208	0	D

F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.7400 to $61.1500, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
F2Holdings include shares acquired in dividend reinvestment transactions.
F3The option vested and became exercisable in three equal installments beginning on 5/4/2012, 5/4/2013 and 5/4/2014.
F4The option vested and became exercisable in three equal installments beginning on 5/7/2011, 5/7/2012, and 5/7/2013.